Together, these results indicate that anti-IFN-γ mAb treatment of infected TSLPR−/− mice abolished the enhanced susceptibility to infection, reduced hepatosplenomegaly, and led to prolonged survival of infected TSLPR−/− mice. The gene discussed is IFNG; the disease is infection.